Humacyte Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Jan '26 Jan 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Market Capitalization	218	650	294	218	747	131	Upgrade
Market Cap Growth	-63.55%	120.90%	35.19%	-70.86%	471.21%	-	Upgrade
Enterprise Value	250	709	251	97	549	-	Upgrade
Last Close Price	1.13	5.05	2.84	2.11	7.25	10.17	Upgrade
PS Ratio	102.97	-	-	139.03	591.27	87.68	Upgrade
PB Ratio	-	-12.34	21.72	1.86	6.11	1.85	Upgrade
P/TBV Ratio	-	-	21.72	1.86	6.11	-	Upgrade
EV/Sales Ratio	158.86	-	-	61.82	434.31	-	Upgrade
Debt / Equity Ratio	-10.73	-1.54	4.29	0.43	0.42	0.41	Upgrade
Asset Turnover	0.02	-	-	0.01	0.01	0.01	Upgrade
Quick Ratio	0.80	2.25	4.36	7.76	20.42	3.57	Upgrade
Current Ratio	1.62	2.40	4.51	7.88	20.76	3.69	Upgrade
Return on Equity (ROE)	-	-	-169.81%	-10.01%	-27.46%	-65.58%	Upgrade
Return on Assets (ROA)	-63.44%	-53.74%	-36.44%	-21.54%	-25.81%	-29.32%	Upgrade
Return on Capital (ROIC)	-210.61%	-142.57%	-50.66%	-31.01%	-37.20%	-31.18%	Upgrade
Return on Capital Employed (ROCE)	-158.80%	-97.00%	-88.30%	-45.80%	-29.50%	-67.70%	Upgrade
Earnings Yield	-16.95%	-22.88%	-37.66%	-5.50%	-3.55%	-50.88%	Upgrade
FCF Yield	-48.79%	-15.34%	-25.70%	-33.17%	-10.90%	-42.75%	Upgrade
Buyback Yield / Dilution	-27.11%	-14.56%	-0.36%	-157.82%	-593.25%	71.34%	Upgrade

Updated Nov 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q